中国继续医学教育
中國繼續醫學教育
중국계속의학교육
China Continuing Medical Education
2015年
24期
170-171
,共2页
急性脑梗死%rt-PA静脉溶栓%临床效果
急性腦梗死%rt-PA靜脈溶栓%臨床效果
급성뇌경사%rt-PA정맥용전%림상효과
Acute cerebral infarction%rt-PA intravenous thrombolysis%Clinical effect
目的：分析急性脑梗死rt-PA静脉溶栓治疗临床效果。方法收集2014年6月～2015年2月45例急性脑梗死患者，将其随机分组。传统组予以抗血小板常规治疗，rt-PA 组患者予以重组组织型纤溶酶原激活剂（rt-PA）静脉溶栓治疗。比较两组总有效率、神经功能缺损情况的不同。结果治疗后患者 NIHSS评分均有所改善，其中 rt-PA 组改善优于传统组，对比差异有统计学意义（P＜0.05）。rt-PA 组患者总有效率高于传统组，对比差异有统计学意义（P＜0.05）。结论 rt-PA 静脉溶栓治疗急性脑梗死有确切的疗效，能促进患者神经功能改善，改善患者预后。
目的：分析急性腦梗死rt-PA靜脈溶栓治療臨床效果。方法收集2014年6月～2015年2月45例急性腦梗死患者，將其隨機分組。傳統組予以抗血小闆常規治療，rt-PA 組患者予以重組組織型纖溶酶原激活劑（rt-PA）靜脈溶栓治療。比較兩組總有效率、神經功能缺損情況的不同。結果治療後患者 NIHSS評分均有所改善，其中 rt-PA 組改善優于傳統組，對比差異有統計學意義（P＜0.05）。rt-PA 組患者總有效率高于傳統組，對比差異有統計學意義（P＜0.05）。結論 rt-PA 靜脈溶栓治療急性腦梗死有確切的療效，能促進患者神經功能改善，改善患者預後。
목적：분석급성뇌경사rt-PA정맥용전치료림상효과。방법수집2014년6월～2015년2월45례급성뇌경사환자，장기수궤분조。전통조여이항혈소판상규치료，rt-PA 조환자여이중조조직형섬용매원격활제（rt-PA）정맥용전치료。비교량조총유효솔、신경공능결손정황적불동。결과치료후환자 NIHSS평분균유소개선，기중 rt-PA 조개선우우전통조，대비차이유통계학의의（P＜0.05）。rt-PA 조환자총유효솔고우전통조，대비차이유통계학의의（P＜0.05）。결론 rt-PA 정맥용전치료급성뇌경사유학절적료효，능촉진환자신경공능개선，개선환자예후。
Objective To analysis of the clinical effect of acute cerebral infarction by intravenous thrombolysis for rt-PA. Methods 45 patients with acute cerebral infarction from June 2014 to February 2015, the random group. Conventional group was treated with anti platelet therapy, rt-PA group was treated with recombinant tissue plasminogen activator (rt-PA). Comparison of two groups of total effective rate, neurological function defect. Results After treatment, the NIHSS score was improved, and the improvement in rt-PA group was significantly higher than that in the traditional group, and the correlation was statistically significant (P<0.05). The total effective rate was significantly higher in the rt-PA group than in the conventional group (P<0.05). Conclusion rt-PA intravenous thrombolytic therapy for acute cerebral infarction has a definite effect, can promote the improvement of neurological function, improve the prognosis of patients.
